Moroxite T

13 jan

On behalf of our customer Moroxite T – a medical research company – we are looking for a CEO


Moroxite AB, a med-tech company, was founded in 2021 by orthopaedic professor Lars Lidgren and business veteran Semmy Rülf together with a research group in Lund with the aim of developing and exploiting a completely new technology to send approved drugs via the bloodstream to an implanted bone mineral.

Moroxite T, with a new and defined application aims to enable the treatment of cancer. The target indication for the product is currently osteosarcoma, an aggressive form of bone cancer with a high risk of spreading. The disease also affects young people.

A research group based in Lund with emeritus Professor Lars Lidgren, Professor Magnus Tägil, PhD Deepak Raina and PhD Liu Yang, has developed a unique method to bind approved tumor drugs to hydroxyapatite, a naturally occurring bone mineral in the body. The group has recently published in scientific journals on artificial injectable bone substitute with hydroxyapatite as a promising carrier material for cytostatics, with local high release in tumor tissue.

Moroxite T have new strong owners and financing through REX International Holding, listed on the Singapore stock exchange. They have invested 43.2 million SEK in the start-up to ensure that research and development successfully should bring this to clinical use.

The Company´s geographical focus is Europe and US.



As the CEO you will makes sure the very promising results and possibilities regarding the technology is further developed in a strategic direction. You understand the journey of commercializing a start-up Medtech Company with high potential. As a seasoned CEO you are used to set and implement strategic plans securing that they are operationalized in clear action plans with short- and long-term tangible milestones and objectives.

The CEO will manage day-to-day operations of Moroxite T.

The right candidate is ready to recruit and build a lean and high performing team, paired with nurturing a pioneering company culture.

The CEO will establish a good working relationship with the board of directors and set the course for company strategy.

Academic and professional background

  • Master’s degree in business/Finance, biology, chemistry or other pharmaceutical or medical technology field


  • The candidate has experience of working in leading positions in preferably smaller Life Science Companies with early phase assets.
  • Experience from Start-ups with the ability to create value through trade sale, mergers, other collaborations.

Used to interact with:

  • Authorities
  • Finance Market, i.e., investors, analysts, and Media.
  • Key Opinion Leaders
  • Experience from launching products on international scale within the Life Science sector.
  • Experience from building and working through lean organizations.


  • Ability to fluidly navigate and integrate at the scientific arena as well as with financial analysists, investor relations duties and the capital market.
  • Solid understanding of the dynamics within Life Science. Positive with experience from early phase (start-up) commercialization.
  • Ability to operationalise strategic directions and decisions in a structured, speedy, and effective way.
  • Knowledge of P&L, balance sheet, cash flow management and general finance and budgeting
  • Excellent communication skills both in speech and writing in English and Swedish is important.
  • Self-motivating, goal-oriented entrepreneurial personality having a significant “can do attitude” with strong sense of urgency.
  • Capability and experience in building high performing teams.
  • Experience from a M&A is a plus
  • Ability to understand new issues quickly and make wise, calculated decisions in a timely manner.
  • Strong negotiator


More information

Morgan Eilenberg, Partner, +46 73 359 05 50 eller [email protected]

Anders Larsson, Partner +46 73 203 46 91, [email protected]

We meet candidates on an ongoing basis, so if you are interested in the position we look forward to receiving your application as soon as possible.

< Tillbaka till filtreringsresultat

Beställ vårt Nyhetsbrev

Med nyhetsbrevet håller du dig uppdaterad när nya jobb kommer in.

Upptäck våra avtalskunder

Söker du arbetskraft inom Life Science
Platsannonsera här!

Årsavtalet ger dig extra synlighet.

På nya positioner

Ledningsförändring i Sobi

Tony Hoos ersätter Anders Ullman som Head of R&D and Medical Affairs och Chief Medical Officer från den...

Abliva utser Dag Nesse till Vice President of Clinical Operations

Abliva AB, ett biotechbolag i klinisk fas som utvecklar läkemedel för behandling av sällsynta och svåra mitokondriella sjukdomar,...

Ny Business Development Manager Nordic på Ashfield

Otto Simonsson tillträder som Business Development Manager Nordic på Ashfield den 2 januari.

Jessica Martinsson blir ny vd på SwedenBIO

SwedenBIO har rekryterat Sprint Biosciences medgrundare och operativa chef Jessica Martinsson som ny vd. Hon kliver in i...

Dylan Ceynowa ny medicinsk chef på Novocure

Dylan Ceynowa har tillträtt tjänsten som Senior Medical Manager på Novocure Sverige. Han är legitimerad läkare och har...

Anders Blanck lämnar Lif och byter bransch

I augusti stod det klart att Anders Blanck lämnar sitt mångåriga uppdrag som vd för Lif – de...

Ny konsult inom klinisk farmakologi på SDS Life Science

David Dahlgren tillträder som konsult inom klinisk farmakologi och DMPK.

Johan Färnstrand ny vd för Lif – de forskande läkemedelsföretagen

Johan Färnstrand tillträder som ny vd för Lif – de forskande läkemedelsföretagen. Johan Färnstrand börjar den 1 mars...

Per Alfredsson ny vd för AstraZeneca i Sverige

AstraZeneca meddelar i dag att Per Alfredsson har utsetts till ny vd för AstraZeneca AB. Han tar över...